A detailed history of Quantbot Technologies LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Quantbot Technologies LP holds 10,834 shares of OCUL stock, worth $94,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,834
Previous 46,500 76.7%
Holding current value
$94,039
Previous $423,000 82.51%
% of portfolio
0.0%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$4.2 - $8.69 $149,797 - $309,937
-35,666 Reduced 76.7%
10,834 $74,000
Q1 2024

May 06, 2024

BUY
$3.85 - $10.93 $179,025 - $508,245
46,500 New
46,500 $423,000
Q1 2023

May 12, 2023

BUY
$2.79 - $6.27 $9,078 - $20,402
3,254 New
3,254 $17,000
Q2 2022

Aug 09, 2022

SELL
$3.01 - $5.22 $382 - $662
-127 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.83 - $7.35 $72,358 - $110,110
-14,981 Reduced 99.16%
127 $0
Q4 2021

Feb 11, 2022

BUY
$6.16 - $12.07 $93,065 - $182,353
15,108 New
15,108 $105,000
Q3 2021

Nov 09, 2021

SELL
$9.7 - $14.34 $30,564 - $45,185
-3,151 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$13.43 - $19.16 $26,201 - $37,381
1,951 Added 162.58%
3,151 $44,000
Q1 2021

May 14, 2021

SELL
$15.82 - $22.11 $19,838 - $27,725
-1,254 Reduced 51.1%
1,200 $19,000
Q4 2020

Feb 12, 2021

SELL
$7.91 - $22.95 $14,459 - $41,952
-1,828 Reduced 42.69%
2,454 $50,000
Q3 2020

Nov 16, 2020

SELL
$7.36 - $9.87 $6,403 - $8,586
-870 Reduced 16.89%
4,282 $32,000
Q2 2020

Aug 13, 2020

BUY
$4.67 - $8.95 $24,059 - $46,110
5,152 New
5,152 $42,000
Q1 2018

May 11, 2018

SELL
$4.66 - $7.08 $6,188 - $9,402
-1,328 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$3.73 - $6.37 $2,238 - $3,822
-600 Reduced 31.12%
1,328 $5,000
Q3 2017

Nov 07, 2017

BUY
$5.28 - $6.88 $10,179 - $13,264
1,928
1,928 $11,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.